Cartilix, maker of tissue repair treatments, sells to Biomet

Cartilix, a Foster City, Calif.-based biotech firm that makes substances capable of repairing human tissues in joints, has sold to Biomet, an Indiana-based seller of tools and products used to help surgeons, according to PE Hub. Neither company disclosed financial terms. Cartilix previously received $6.5 million in first-round venture funding from De Novo Ventures.

Next Story: Google to buy mobile advertising network AdMob for $750 million
Previous Story: Founder Collective fund rounds up Flickr, LiveOps co-founders and $40 million